Zentalis Pharmaceuticals Inc [ZNTL]

Source: 

Company Overview

Zentalis Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor, for patients with ovarian cancer and other tumor types.